APA (7th ed.) Citation

Ren, X., Wu, J., Li, J., Zhai, Z., Li, X., Guan, F., . . . Lin, S. (2025). Bisecting GlcNAc enhances CD8+ T cell-mediated killing of breast cancer by suppressing PD-L1 expression and its binding to PD-1. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00693-w

Chicago Style (17th ed.) Citation

Ren, Xueting, et al. "Bisecting GlcNAc Enhances CD8+ T Cell-mediated Killing of Breast Cancer by Suppressing PD-L1 Expression and Its Binding to PD-1." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00693-w.

MLA (9th ed.) Citation

Ren, Xueting, et al. "Bisecting GlcNAc Enhances CD8+ T Cell-mediated Killing of Breast Cancer by Suppressing PD-L1 Expression and Its Binding to PD-1." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00693-w.